Who owns Brekiya?
Brekiya is owned by Amneal (the United States, NASDAQ: AMRX).[1]
Evidence: Amneal Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27, SEC EDGAR, 27 February 2026. Verified from filings; last checked .
Key facts
- Current owner
- Amneal Pharmaceuticals, Inc. verified
- Owner HQ
- 🇺🇸 United States, Bridgewater
- Origin
- 🇺🇸 United States
- Founded
- 2025
- Category
- Healthcare & pharma › Drug makers › Pharmaceuticals
- Parent ticker
- NASDAQ: AMRX
- Last verified
- · 1 sources
About Brekiya
Brekiya is a dihydroergotamine mesylate autoinjector for the acute treatment of migraine and cluster headache in adults. Amneal's 2025 10-K says the FDA approved it in May 2025 and it launched in the United States in October 2025, calling it the first ready-to-use autoinjector of its kind.
Ownership timeline of Brekiya
Where Brekiya sits in Amneal
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Open the full Amneal ownership tree →
See the full Amneal brand portfolio (6) →
Other brands owned by Amneal
Amneal controls 6 brands on Brandtree, 6 of them in healthcare & pharma.
Also in healthcare & pharma
Other brands in pharmaceuticals, and who owns them
The 13 brands in pharmaceuticals on Brandtree belong to 5 owners. The largest is Teva, with 4; Amneal has 2.
About the owner: Amneal
Amneal is a publicly listed company headquartered in Bridgewater, United States. Brandtree records 6 brands under its control, and it is listed as NASDAQ: AMRX.
Amneal Pharmaceuticals is a Bridgewater, New Jersey drugmaker whose 10-K for 2025 describes three segments: Affordable Medicines (generics, injectables and biosimilars), Specialty (branded products for central nervous system and endocrine disorders) and AvKARE, a pharmaceutical distributor. It had over 8,500 employees at 31 December 2025 and operates in the United States, India and Ireland.
🇺🇸 Brekiya and other American brands
Brandtree records a controlling owner for 2,399 brands that began in the United States. 461 of them (19%) are now controlled by a company headquartered in another country; Brekiya is not one of them.
Frequently asked questions
Who is the parent company of Brekiya?
The parent company of Brekiya is Amneal, a publicly listed company headquartered in the United States.
Is Brekiya American?
Yes. Brekiya originated in the United States in 2025 and its owner, Amneal, is also headquartered in the United States.
Is Brekiya still owned by Amneal?
Yes. As of 14 October 2026, Brekiya is still owned by Amneal. The ownership record was last checked against primary sources on that date.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Amneal Pharmaceuticals, Inc. Annual Report on Form 10-K filed 2026-02-27 — SEC EDGAR, SEC Form 10-K, published 27 February 2026; retrieved 14 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.